Ashton Thomas Private Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Buy
2,877
+195
+7% +$51.3K 0.02% 622
2026
Q1
$716K Buy
2,682
+263
+11% +$71.2K 0.02% 633
2025
Q4
$607K Buy
2,419
+291
+14% +$77.3K 0.01% 616
2025
Q3
$611K Buy
2,128
+639
+43% +$171K 0.02% 598
2025
Q2
$391K Buy
+1,489
New +$363K 0.01% 629
2024
Q3
Sell
-580
Closed -$118K 1296
2024
Q2
$118K Buy
+580
New +$118K 0.01% 714
2023
Q1
Sell
-1,012
Closed -$205K 513
2022
Q4
$205K Buy
+1,012
New +$198K 0.02% 452

Other funds holding LH

Ashton Thomas Private Wealth's LH Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Labcorp (LH) stake by 7.3% in Q2 2026, buying an estimated $51.3K and bringing the position to 2,877 shares worth $806K. The position accounts for 0.02% of the portfolio, ranked #622.

Ashton Thomas Private Wealth first reported a position in LH in Q4 2022 and has held it in 7 quarters since. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ashton Thomas Private Wealth held 2,877 shares of Labcorp worth $806K as of Q2 2026.
  • Ashton Thomas Private Wealth bought 195 Labcorp shares in Q2 2026, an estimated $51.3K.
  • Labcorp made up 0.02% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #622 holding.
  • Ashton Thomas Private Wealth first reported a position in Labcorp in Q4 2022 and has held it in 7 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.